Literature DB >> 24536077

Biomarkers and response to bevacizumab--response.

Fiona Collinson1, Michelle Hutchinson, Rachel A Craven, David A Cairns, Zougman Alexandre, Tobias C Wind, Narinder Gahir, Michael P Messenger, Sharon Jackson, Douglas Thompson, Cybil Adusei, Jonathan Ledermann, Geoffrey Hall, Gordon C Jayson, Peter J Selby, Rosamonde E Banks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24536077     DOI: 10.1158/1078-0432.CCR-13-3269

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  1 in total

1.  Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non-Small Cell Lung Carcinoma.

Authors:  Diane-Charlotte Imbs; Raouf El Cheikh; Arnaud Boyer; Joseph Ciccolini; Céline Mascaux; Bruno Lacarelle; Fabrice Barlesi; Dominique Barbolosi; Sébastien Benzekry
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.